Income Tax Expense (Benefit) in USD of DiaMedica Therapeutics Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2018 to Q3 2025.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $6K, a 14.3% decline year-over-year.
  • DiaMedica Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $27K, a 37.2% decline year-over-year.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2024 was $30K, a 30.2% decline from 2023.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $43K, a 53.6% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $28K, unchanged from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

DiaMedica Therapeutics Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $27K $6K -$1K -14.3% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $28K $6K -$1K -14.3% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $29K $6K -$1K -14.3% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $30K $9K -$13K -59.1% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 $43K $7K $0 0% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $43K $7K $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $43K $7K $0 0% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 $43K $22K +$15K +214% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 $28K $7K $0 0% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $28K $7K $0 0% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $28K $7K $0 0% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $28K $7K $0 0% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 $28K $7K $0 0% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $28K $7K $0 0% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $28K $7K $0 0% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $28K $7K $0 0% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2023
Q3 2021 $28K $7K +$5K +250% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $23K $7K -$2K -22.2% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $25K $7K -$2K -22.2% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $27K $7K +$5K +250% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 $22K $2K -$10K -83.3% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $32K $9K +$1K +12.5% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 $31K $9K $0 0% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $31K $2K -$4K -66.7% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2021
Q3 2019 $35K $12K -$45K -78.9% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $80K $8K -$8K -50% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $88K $9K +$8K +800% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $80K $6K 01 Oct 2018 31 Dec 2018 10-K 23 Mar 2020
Q3 2018 $57K 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $16K 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019
Q1 2018 $1K 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019

DiaMedica Therapeutics Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $30K -$13K -30.2% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 $43K +$15K +53.6% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 $28K $0 0% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024
2021 $28K +$1K +3.7% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2023
2020 $27K -$4K -12.9% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 $31K -$49K -61.3% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2021
2018 $80K 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.